Re-evaluation of the effectiveness and safety of Xiaoerfeireqing Granules after listing on the market

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023802

Enrollment

Unknown

Registered

2019-06-12

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute bronchitis

Interventions

Case series:Taking Xiaoerfeireqing Granules

Eligibility

Sex/Gender

All

Age

1 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Patients who prescribe pediatric lung heat clear granules; (2) Aged 1-14 years old; (3) Patients who signed informed consent.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Total effective rate of disease;Single symptom and sign disappearance rate;Antipyretic time;	—

Countries

China

Contacts

Public ContactZhao Dong-Chi

Zhongnan Hospital of Wuhan University

83024940@qq.com+86 027-67813167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026